We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Rapid Malaria Tests Accuracy Assessed for Hospitalized Child

By LabMedica International staff writers
Posted on 27 Jan 2014
Rapid diagnostic tests for malaria are now extensively used in Africa to fulfill the need of parasite-based diagnosis, which means the parasitological confirmation of malaria before the start of treatment. More...


Most RDTs used detect Plasmodium falciparum histidine-rich protein-2 (PfHRP2), though P. falciparum-specific parasite lactate dehydrogenase (Pf-pLDH)-detecting RDTs may have advantages over PfHRP2-detecting RDTs.

Clinical scientist from the Institute of Tropical Medicine (Antwerp, Belgium) carried out one-year survey during 2012 and 2013 in a rural area in the center-west region of Burkina Faso to assess proportions and incidence rates of invasive bacterial infections and severe malaria. Thick blood films (TBF) were stained with Giemsa and assessed for the presence of malarial parasites according to standard procedures.

The malaria rapid diagnostic tests evaluated were the RDT SD Bioline Malaria Antigen P.f (HRP2/pLDH) further referred to as SD90 and the SD50 that detects the protein PfHRP2 (Standard Diagnostics; Hagal-Dong, Republic of Korea).The SD 90 assay is a three-band test consisting of a control line and two test lines targeting PfHRP2 and Pf-pLDH. Real-time polymerase chain reaction (PCR) was performed in case of discordant results between microscopy and RDT.

During the one-year study period, 696 children, aged one month to 14 years, were included in the investigation. In 376 (54.0%) children, samples were P. falciparum positive; five of them had a mixed infection with P. malariae or P. ovale. Median P. falciparum parasite density was 43,231.5/μL. Among the 318 P. falciparum negative samples, two had P. ovale infection and 13 had pure P. falciparum gametocytaemia.

No invalid results were observed for the SD90 RDT. Among the P. falciparum-positive samples, PfHRP2 was positive in all samples while Pf-pLDH missed only one, resulting in an overall sensitivity of 100 and 99.5% for PfHRP2 and Pf-pLDH, respectively. Among the P. falciparum-negative samples, there were 139 PfHRP2and 29 Pf-pLDH false-positive lines corresponding to specificities of 56.3% and 90.9% respectively. For both detection antigens, specificity was lowest for children one to five years and in the rainy season.

The authors concluded that among children presenting with severe febrile illness in a seasonal hyperendemic malaria-transmission area, they observed similar sensitivity but lower specificity of PfHRP2 compared to Pf-pLDH-detection. They suggest that future studies should assess the diagnostic accuracy and safety of an appropriate Pf-pLDH-detecting RDT in field settings and if satisfying, replacement of PfHRP2 by Pf-pLDH-detecting RDTs should be considered. The study was published on January 13, 2014, in the Malaria Journal.

Related Links:

Institute of Tropical Medicine  
Standard Diagnostics



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Spinal Fluid Cell Count Control
Spinalscopics
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.